These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26893558)

  • 1. Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene.
    Luo L; Du T; Zhang J; Zhao W; Cheng H; Yang Y; Wu Y; Wang C; Men K; Gou M
    Int J Nanomedicine; 2016; 11():501-12. PubMed ID: 26893558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A.
    Zhang L; Gao X; Men K; Wang B; Zhang S; Qiu J; Huang M; Gou M; Huang N; Qian Z; Zhao X; Wei Y
    Int J Nanomedicine; 2011; 6():2419-27. PubMed ID: 22072877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.
    Yang F; Gou M; Deng H; Yi T; Zhong Q; Wei Y; Zhao X
    Oncol Rep; 2012 Aug; 28(2):668-76. PubMed ID: 22684947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient Inhibition of Ovarian Cancer by Gelonin Toxin Gene Delivered by Biodegradable Cationic Heparin-polyethyleneimine Nanogels.
    Bai Y; Gou M; Yi T; Yang L; Liu L; Lin X; Su D; Wei Y; Zhao X
    Int J Med Sci; 2015; 12(5):397-406. PubMed ID: 26005374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient inhibition of an intraperitoneal xenograft model of human ovarian cancer by HSulf-1 gene delivered by biodegradable cationic heparin-polyethyleneimine nanogels.
    Liu P; Gou M; Yi T; Xie C; Qi X; Zhou S; Deng H; Wei Y; Zhao X
    Oncol Rep; 2012 Feb; 27(2):363-70. PubMed ID: 22086394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Assembled Nanoparticle Mediated
    Xiao Y; Wang C; Xiong M; Yang Y; Zhang Q; Liu X; Zou B; Gou M
    J Biomed Nanotechnol; 2018 Dec; 14(12):2092-2101. PubMed ID: 30305216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient inhibition of ovarian cancer by truncation mutant of FILIP1L gene delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.
    Xie C; Gou ML; Yi T; Deng H; Li ZY; Liu P; Qi XR; He X; Wei Y; Zhao X
    Hum Gene Ther; 2011 Nov; 22(11):1413-22. PubMed ID: 21513424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The enhanced antitumor effects of biodegradable cationic heparin-polyethyleneimine nanogels delivering HSulf-1 gene combined with cisplatin on ovarian cancer.
    Liu P; Gou M; Yi T; Qi X; Xie C; Zhou S; Deng H; Wei Y; Zhao X
    Int J Oncol; 2012 Oct; 41(4):1504-12. PubMed ID: 22825572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation of recombinant HIV-TATm-survivin (T34A) protein and its pro-apoptosis activity to cancer cells in vitro].
    Zheng WY; Ma XY; Wei DZ; Wang JZ; Liu QH; Ma YS; Yang SL
    Sheng Wu Gong Cheng Xue Bao; 2006 Mar; 22(2):285-92. PubMed ID: 16607958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of heparin-polyethyleneimine nanogels delivering claudin-3-targeted short hairpin RNA combined with low-dose cisplatin on ovarian cancer.
    Liu L; Gou M; Yi T; Bai Y; Wei Y; Zhao X
    Oncol Rep; 2014 Apr; 31(4):1623-8. PubMed ID: 24482188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-level expression, purification and pro-apoptosis activity of HIV-TAT-survivin (T34A) mutant to cancer cells in vitro.
    Ma X; Zheng W; Wei D; Ma Y; Wang T; Wang J; Liu Q; Yang S
    J Biotechnol; 2006 May; 123(3):367-78. PubMed ID: 16406157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction, expression, and purification of HIV-TAT-survivin (T34A) mutant: a pro-apoptosis protein in Escherichia coli.
    Ma X; Zheng W; Wei D; Ma Y; Wang T; Wang J; Liu Q; Yang S
    Protein Expr Purif; 2006 May; 47(1):36-44. PubMed ID: 16260148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy.
    McKay TR; Bell S; Tenev T; Stoll V; Lopes R; Lemoine NR; McNeish IA
    Oncogene; 2003 Jun; 22(23):3539-47. PubMed ID: 12789262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local and systemic delivery of mRNA encoding survivin-T34A by lipoplex for efficient colon cancer gene therapy.
    Zhang X; Men K; Zhang Y; Zhang R; Yang L; Duan X
    Int J Nanomedicine; 2019; 14():2733-2751. PubMed ID: 31118608
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anti-prostate cancer activity of Survivin-T34A mutant in vitro and in vivo].
    Pan L; Peng XC; Yuan QZ; Leng F; Yu DD; Shan Y; Li ZY; Wang CT
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 May; 41(3):390-3. PubMed ID: 20629305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenoviral vectors modified by heparin-polyethyleneimine nanogels enhance targeting to the lung and show therapeutic potential for pulmonary metastasis in vivo.
    Wei W; Mu Y; Li X; Gou M; Zhang H; Luo S; Men K; Mao Y; Qian Z; Yang L
    J Biomed Nanotechnol; 2011 Dec; 7(6):768-75. PubMed ID: 22416575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of human epithelial ovarian cancer HO-8910 cells with modified survivin gene on the cell cycle distribution and chemosensitivity].
    Peng LP; Huang JM; Zhang GN; Zha X; Ren Y; Fan Y; Deng BF
    Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):860-4. PubMed ID: 21211287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-->Ala mutant.
    Peng XC; Yang L; Yang LP; Mao YQ; Yang HS; Liu JY; Zhang DM; Chen LJ; Wei YQ
    J Exp Clin Cancer Res; 2008 Sep; 27(1):46. PubMed ID: 18816410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumoral efficacy by systemic delivery of heparin conjugated polyethylenimine-plasmid interleukin-15 complexes in murine models of lung metastasis.
    Zhou X; Li X; Gou M; Qiu J; Li J; Yu C; Zhang Y; Zhang N; Teng X; Chen Z; Luo C; Wang Z; Liu X; Shen G; Yang L; Qian Z; Wei Y; Li J
    Cancer Sci; 2011 Jul; 102(7):1403-9. PubMed ID: 21564417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic protein TmSm(T34A) enhances sensitivity of chemotherapy to breast cancer cell lines as a synergistic drug to doxorubicin.
    Xu Y; Zheng W; Wang T; Wang P; Zhu L; Ma X
    Biomed Pharmacother; 2012 Jul; 66(5):368-72. PubMed ID: 22560635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.